TreeWAS – Variant ID: rs17049741

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K35.9 Acute appendicitis, unspecified	0.379	0.621	0.000
K35 Acute appendicitis	0.340	0.660	0.000
K35.0 Acute appendicitis with generalised peritonitis	0.330	0.670	0.000
K35.3 Acute appendicitis with localized peritonitis	0.323	0.677	0.000
K35.2 Acute appendicitis with generalized peritonitis	0.182	0.817	0.000
K35.8 Acute appendicitis, other and unspecified	0.174	0.826	0.000
K35.1 Acute appendicitis with peritoneal abscess	0.166	0.834	0.000
K35-K38 Diseases of appendix	0.087	0.913	0.000
K38 Other diseases of appendix	0.062	0.937	0.000
K37 Unspecified appendicitis	0.059	0.941	0.000
K38.8 Other specified diseases of appendix	0.051	0.949	0.000
K38.0 Hyperplasia of appendix	0.046	0.953	0.000
K38.3 Fistula of appendix	0.045	0.955	0.000
K38.2 Diverticulum of appendix	0.045	0.955	0.000
K38.9 Disease of appendix, unspecified	0.044	0.955	0.000
K36 Other appendicitis	0.041	0.959	0.000
K38.1 Appendicular concretions	0.035	0.965	0.000
C54.1 Endometrium	0.000	0.972	0.028
C54 Malignant neoplasm of corpus uteri	0.000	0.980	0.020
C54.9 Corpus uteri, unspecified	0.000	0.984	0.016
C54.8 Overlapping lesion of corpus uteri	0.000	0.986	0.014
C54.3 Fundus uteri	0.000	0.986	0.014
C54.2 Myometrium	0.000	0.986	0.014
C54.0 Isthmus uteri	0.000	0.986	0.014
L72.0 Epidermal cyst	0.014	0.986	0.000
C51-C58 Malignant neoplasms of female genital organs	0.000	0.989	0.011
C85.1 B-cell lymphoma, unspecified	0.000	0.990	0.010
C57 Malignant neoplasm of other and unspecified female genital organs	0.000	0.990	0.010
C57.0 Fallopian tube	0.000	0.991	0.009
C52 Malignant neoplasm of vagina	0.000	0.991	0.009
T43.0 Tricyclic and tetracyclic antidepressants	0.009	0.991	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.992	0.008
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.992	0.008
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.008	0.992	0.000
C58 Malignant neoplasm of placenta	0.000	0.992	0.008
T43.3 Phenothiazine antipsychotics and neuroleptics	0.008	0.992	0.000
C53 Malignant neoplasm of cervix uteri	0.000	0.992	0.008
C51 Malignant neoplasm of vulva	0.000	0.992	0.008
C55 Malignant neoplasm of uterus, part unspecified	0.000	0.993	0.007
C56 Malignant neoplasm of ovary	0.000	0.993	0.007
T43.5 Other and unspecified antipsychotics and neuroleptics	0.007	0.993	0.000
Q50.4 Embryonic cyst of Fallopian tube	0.007	0.993	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.993	0.007
C57.9 Female genital organ, unspecified	0.000	0.993	0.007
C57.8 Overlapping lesion of female genital organs	0.000	0.993	0.007
C57.7 Other specified female genital organs	0.000	0.993	0.007
C57.4 Uterine adnexa, unspecified	0.000	0.993	0.007
C57.3 Parametrium	0.000	0.993	0.007
C57.2 Round ligament	0.000	0.993	0.007
C57.1 Broad ligament	0.000	0.993	0.007
E27 Other disorders of adrenal gland	0.000	0.993	0.007
T43.6 Psychostimulants with abuse potential	0.007	0.993	0.000
E27.9 Disorder of adrenal gland, unspecified	0.000	0.993	0.007
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.006	0.993	0.000
E27.2 Addisonian crisis	0.000	0.993	0.007
T43.4 Butyrophenone and thioxanthene neuroleptics	0.006	0.993	0.000
E27.1 Primary adrenocortical insufficiency	0.000	0.994	0.006
N93.9 Abnormal uterine and vaginal bleeding, unspecified	0.006	0.994	0.000
C85.0 Lymphosarcoma	0.000	0.994	0.006
T43.9 Psychotropic drug, unspecified	0.006	0.994	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.006	0.994	0.000
C53.9 Cervix uteri, unspecified	0.000	0.994	0.006
E28.2 Polycystic ovarian syndrome	0.000	0.994	0.006
C53.8 Overlapping lesion of cervix uteri	0.000	0.994	0.006
C53.1 Exocervix	0.000	0.994	0.006
G30.9 Alzheimer's disease, unspecified	0.006	0.994	0.000
E28 Ovarian dysfunction	0.000	0.994	0.006
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.994	0.006
C51.8 Overlapping lesion of vulva	0.000	0.994	0.006
C51.2 Clitoris	0.000	0.994	0.006
C51.1 Labium minus	0.000	0.994	0.006
C51.0 Labium majus	0.000	0.994	0.006
E28.3 Primary ovarian failure	0.000	0.994	0.006
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.994	0.006
E27.8 Other specified disorders of adrenal gland	0.000	0.995	0.005
C51.9 Vulva, unspecified	0.000	0.995	0.005
E27.5 Adrenomedullary hyperfunction	0.000	0.995	0.005
E27.0 Other adrenocortical overactivity	0.000	0.995	0.005
C53.0 Endocervix	0.000	0.995	0.005
G30 Alzheimer's disease	0.005	0.995	0.000
E20-E35 Disorders of other endocrine glands	0.000	0.995	0.005
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.995	0.005
D03.5 Melanoma in situ of trunk	0.005	0.995	0.000
E22 Hyperfunction of pituitary gland	0.000	0.995	0.005
S92.30 Fracture of metatarsal bone (closed)	0.004	0.996	0.000
E28.9 Ovarian dysfunction, unspecified	0.000	0.996	0.004
E28.8 Other ovarian dysfunction	0.000	0.996	0.004
E28.1 Androgen excess	0.000	0.996	0.004
E28.0 Oestrogen excess	0.000	0.996	0.004
G30.0 Alzheimer's disease with early onset	0.004	0.996	0.000
G30.1 Alzheimer's disease with late onset	0.004	0.996	0.000
J92.0 Pleural plaque with presence of asbestos	0.004	0.996	0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.004	0.996	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.000	0.996	0.004
T36-T50 Poisoning by drugs, medicaments and biological substances	0.004	0.996	0.000
G30.8 Other Alzheimer's disease	0.004	0.996	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.004	0.996	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.004	0.996	0.000
E22.0 Acromegaly and pituitary gigantism	0.000	0.996	0.004
T42.4 Benzodiazepines	0.004	0.996	0.000
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.004	0.996	0.000
T45.2 Vitamins, not elsewhere classified	0.004	0.996	0.000
E24 Cushing's syndrome	0.000	0.996	0.004
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.004	0.996	0.000
T43.2 Other and unspecified antidepressants	0.004	0.996	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.996	0.004
H57.9 Disorder of eye and adnexa, unspecified	0.004	0.996	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.996	0.004
E32 Diseases of thymus	0.000	0.996	0.004
E31 Polyglandular dysfunction	0.000	0.996	0.004
E30 Disorders of puberty, not elsewhere classified	0.000	0.996	0.004
E25 Adrenogenital disorders	0.000	0.996	0.004
T36 Poisoning by systemic antibiotics	0.004	0.996	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.000	0.996	0.003
E22.8 Other hyperfunction of pituitary gland	0.000	0.996	0.003
T45.5 Anticoagulants	0.003	0.996	0.000
T42.1 Iminostilbenes	0.003	0.996	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.996	0.000
E26 Hyperaldosteronism	0.000	0.996	0.003
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.996	0.000
S32.80 Fracture of other and unspecified parts of lumbar spine and pelvis (closed)	0.003	0.997	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
S62.61 Fracture of other finger (open)	0.000	0.997	0.003
Q50.6 Other congenital malformatons of Fallopian tube and broad ligament	0.003	0.997	0.000
Q50.5 Embryonic cyst of broad ligament	0.003	0.997	0.000
Q50.3 Other congenital malformations of ovary	0.003	0.997	0.000
Q50.2 Congenital torsion of ovary	0.003	0.997	0.000
Q50.1 Developmental ovarian cyst	0.003	0.997	0.000
Q50.0 Congenital absence of ovary	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
J33.9 Nasal polyp, unspecified	0.003	0.997	0.000
E22.1 Hyperprolactinaemia	0.000	0.997	0.003
E21.3 Hyperparathyroidism, unspecified	0.000	0.997	0.003
T42.5 Mixed antiepileptics, not elsewhere classified	0.003	0.997	0.000
T42.3 Barbiturates	0.003	0.997	0.000
T42.2 Succinimides and oxazolidinediones	0.003	0.997	0.000
E29 Testicular dysfunction	0.000	0.997	0.003
E21.0 Primary hyperparathyroidism	0.000	0.997	0.003
E24.0 Pituitary-dependent Cushing's disease	0.000	0.997	0.003
E20 Hypoparathyroidism	0.000	0.997	0.003
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
T36.0 Penicillins	0.003	0.997	0.000
G93.0 Cerebral cysts	0.000	0.997	0.003
E23 Hypofunction and other disorders of pituitary gland	0.000	0.997	0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
E24.8 Other Cushing's syndrome	0.000	0.997	0.003
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.000	0.997	0.003
E24.3 Ectopic ACTH syndrome	0.000	0.997	0.003
E24.1 Nelson's syndrome	0.000	0.997	0.003
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
S92.3 Fracture of metatarsal bone	0.003	0.997	0.000
E24.2 Drug-induced Cushing's syndrome	0.000	0.997	0.003
E21.4 Other specified disorders of parathyroid gland	0.000	0.997	0.003
E24.9 Cushing's syndrome, unspecified	0.000	0.997	0.003
S32.7 Multiple fractures of lumbar spine and pelvis	0.003	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
G20 Parkinson's disease	0.003	0.997	0.000
E30.9 Disorder of puberty, unspecified	0.000	0.997	0.003
E30.8 Other disorders of puberty	0.000	0.997	0.003
E30.1 Precocious puberty	0.000	0.997	0.003
E30.0 Delayed puberty	0.000	0.997	0.003
E31.9 Polyglandular dysfunction, unspecified	0.000	0.997	0.003
E31.8 Other polyglandular dysfunction	0.000	0.997	0.003
E31.1 Polyglandular hyperfunction	0.000	0.997	0.003
E31.0 Autoimmune polyglandular failure	0.000	0.997	0.003
E32.9 Disease of thymus, unspecified	0.000	0.997	0.003
E32.8 Other diseases of thymus	0.000	0.997	0.003
E32.1 Abscess of thymus	0.000	0.997	0.003
E32.0 Persistent hyperplasia of thymus	0.000	0.997	0.003
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.000	0.997	0.003
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.000	0.997	0.003
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.000	0.997	0.003
E25.9 Adrenogenital disorder, unspecified	0.000	0.997	0.003
E25.8 Other adrenogenital disorders	0.000	0.997	0.003
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.003	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
T36.6 Rifamycins	0.003	0.997	0.000
T36.5 Aminoglycosides	0.003	0.997	0.000
T36.4 Tetracyclines	0.003	0.997	0.000
T36.3 Macrolides	0.003	0.997	0.000
T36.2 Chloramphenicol group	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.000	0.997	0.003
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.4 Other laxatives	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.003	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.997	0.000
E26.9 Hyperaldosteronism, unspecified	0.000	0.997	0.003
E26.8 Other hyperaldosteronism	0.000	0.997	0.003
E26.1 Secondary hyperaldosteronism	0.000	0.997	0.003
T42.0 Hydantoin derivatives	0.003	0.997	0.000
S32.8 Fracture of other and unspecified parts of lumbar spine and pelvis	0.003	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
T46.7 Peripheral vasodilators	0.003	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
E21.2 Other hyperparathyroidism	0.000	0.997	0.003
H93.1 Tinnitus	0.000	0.997	0.003
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
T37.5 Antiviral drugs	0.003	0.997	0.000
T37.4 Anthelminthics	0.003	0.997	0.000
T37.3 Other antiprotozoal drugs	0.003	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
T37.1 Antimycobacterial drugs	0.003	0.997	0.000
T37.0 Sulphonamides	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.003	0.997	0.000
T48.4 Expectorants	0.003	0.997	0.000
T48.3 Antitussives	0.003	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
T48.0 Oxytocic drugs	0.003	0.997	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.003	0.997	0.000
E23.0 Hypopituitarism	0.000	0.997	0.003
Y84.6 Urinary catheterisation	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.000	0.997	0.003
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
T41.5 Therapeutic gases	0.002	0.997	0.000
T41.4 Anaesthetic, unspecified	0.002	0.997	0.000
T41.3 Local anaesthetics	0.002	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.997	0.000
T41.1 Intravenous anaesthetics	0.002	0.997	0.000
T41.0 Inhaled anaesthetics	0.002	0.997	0.000
T49.9 Topical agent, unspecified	0.002	0.997	0.000
T49.8 Other topical agents	0.002	0.997	0.000
T49.7 Dental drugs, topically applied	0.002	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.997	0.000
T49.2 Local astringents and local detergents	0.002	0.997	0.000
T49.1 Antipruritics	0.002	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.997	0.000
L97 Ulcer of lower limb, not elsewhere classified	0.003	0.997	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.003	0.997	0.000
T40.4 Other synthetic narcotics	0.003	0.997	0.000
E29.9 Testicular dysfunction, unspecified	0.000	0.997	0.002
E29.8 Other testicular dysfunction	0.000	0.997	0.002
E29.0 Testicular hyperfunction	0.000	0.997	0.002
E20.8 Other hypoparathyroidism	0.000	0.997	0.002
E20.1 Pseudohypoparathyroidism	0.000	0.997	0.002
E20.0 Idiopathic hypoparathyroidism	0.000	0.997	0.002
E26.0 Primary hyperaldosteronism	0.000	0.997	0.002
G44.0 Cluster headache syndrome	0.000	0.997	0.003
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.997	0.002
M79.10 Myalgia (Multiple sites)	0.003	0.997	0.000
G93.2 Benign intracranial hypertension	0.000	0.997	0.002
N18.4 Chronic kidney disease, stage 4	0.000	0.997	0.003
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.000	0.998	0.002
E23.1 Drug-induced hypopituitarism	0.000	0.998	0.002
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
S92.31 Fracture of metatarsal bone (open)	0.002	0.998	0.000
Q54.0 Hypospadias, balanic	0.002	0.998	0.000
S32.71 Multiple fractures of lumbar spine and pelvis (open)	0.002	0.998	0.000
H59.8 Other postprocedural disorders of eye and adnexa	0.000	0.998	0.002
I69.1 Sequelae of intracerebral haemorrhage	0.000	0.998	0.002
Z80.9 Family history of malignant neoplasm, unspecified	0.002	0.998	0.000
K70.9 Alcoholic liver disease, unspecified	0.000	0.998	0.002
E34 Other endocrine disorders	0.000	0.998	0.002
G93.9 Disorder of brain, unspecified	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.002	0.998	0.000
E23.7 Disorder of pituitary gland, unspecified	0.000	0.998	0.002
M79.16 Myalgia (Lower leg)	0.002	0.998	0.000
S32.81 Fracture of other and unspecified parts of lumbar spine and pelvis (open)	0.002	0.998	0.000
S32 Fracture of lumbar spine and pelvis	0.002	0.998	0.000
M96.8 Other postprocedural musculoskeletal disorders	0.000	0.998	0.002
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.5 Cocaine	0.002	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
T40.1 Heroin	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
Q54 Hypospadias	0.002	0.998	0.000
H93.8 Other specified disorders of ear	0.000	0.998	0.002
B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
G93 Other disorders of brain	0.000	0.998	0.002
E23.6 Other disorders of pituitary gland	0.000	0.998	0.002
M79.1 Myalgia	0.002	0.998	0.000
S32.0 Fracture of lumbar vertebra	0.002	0.998	0.000
T78.1 Other adverse food reactions, not elsewhere classified	0.002	0.998	0.000
Q54.9 Hypospadias, unspecified	0.002	0.998	0.000
H20.9 Iridocyclitis, unspecified	0.000	0.998	0.002
S32.00 Fracture of lumbar vertebra (closed)	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
E20.9 Hypoparathyroidism, unspecified	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
H93 Other disorders of ear, not elsewhere classified	0.000	0.998	0.002
E29.1 Testicular hypofunction	0.000	0.998	0.002
M96.0 Pseudarthrosis after fusion or arthrodesis	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
M79.18 Myalgia (Other)	0.002	0.998	0.000
M96.1 Postlaminectomy syndrome, not elsewhere classified	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
Q50-Q56 Congenital malformations of genital organs	0.002	0.998	0.000
E34.5 Androgen resistance syndrome	0.000	0.998	0.002
E34.4 Constitutional tall stature	0.000	0.998	0.002
E34.3 Short stature, not elsewhere classified	0.000	0.998	0.002
E34.2 Ectopic hormone secretion, not elsewhere classified	0.000	0.998	0.002
E34.1 Other hypersecretion of intestinal hormones	0.000	0.998	0.002
D03 Melanoma in situ	0.002	0.998	0.000
M96 Postprocedural musculoskeletal disorders, not elsewhere classified	0.000	0.998	0.002
T50.8 Diagnostic agents	0.002	0.998	0.000
D03.3 Melanoma in situ of other and unspecified parts of face	0.002	0.998	0.000
G93.5 Compression of brain	0.000	0.998	0.002
K74.6 Other and unspecified cirrhosis of liver	0.000	0.998	0.002
M79.11 Myalgia (Shoulder region)	0.002	0.998	0.000
S32.4 Fracture of acetabulum	0.002	0.998	0.000
S32.2 Fracture of coccyx	0.002	0.998	0.000
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
M79.15 Myalgia (Pelvic region and thigh)	0.002	0.998	0.000
R85.7 Abnormal histological findings	0.002	0.998	0.000
K70.3 Alcoholic cirrhosis of liver	0.000	0.998	0.002
Q54.8 Other hypospadias	0.002	0.998	0.000
Q54.4 Congenital chordee	0.002	0.998	0.000
Q54.3 Hypospadias, perineal	0.002	0.998	0.000
Q54.2 Hypospadias, penoscrotal	0.002	0.998	0.000
M79.19 Myalgia (Site unspecified)	0.002	0.998	0.000
G93.6 Cerebral oedema	0.000	0.998	0.002
O24.4 Diabetes mellitus arising in pregnancy	0.002	0.998	0.000
Z93.6 Other artificial openings of urinary tract status	0.002	0.998	0.000
S92.20 Fracture of other tarsal bone(s) (closed)	0.002	0.998	0.000
E23.2 Diabetes insipidus	0.000	0.998	0.002
G93.7 Reye's syndrome	0.000	0.998	0.002
M79.17 Myalgia (Ankle and foot)	0.002	0.998	0.000
M79.14 Myalgia (Hand)	0.002	0.998	0.000
M79.13 Myalgia (Forearm)	0.002	0.998	0.000
M79.12 Myalgia (Upper arm)	0.002	0.998	0.000
S32.01 Fracture of lumbar vertebra (open)	0.002	0.998	0.000
S92 Fracture of foot, except ankle	0.002	0.998	0.000
D03.2 Melanoma in situ of ear and external auricular canal	0.002	0.998	0.000
S92.2 Fracture of other tarsal bone(s)	0.002	0.998	0.000
K70 Alcoholic liver disease	0.000	0.998	0.002
E34.8 Other specified endocrine disorders	0.000	0.998	0.001
Q55 Other congenital malformations of male genital organs	0.002	0.998	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.000	0.998	0.002
S92.7 Multiple fractures of foot	0.002	0.998	0.000
S92.70 Multiple fractures of foot (closed)	0.002	0.998	0.000
R85.5 Abnormal microbiological findings	0.002	0.998	0.000
W44.0 Home	0.002	0.998	0.000
W45.8 Other specified place	0.002	0.998	0.000
H93.3 Disorders of acoustic nerve	0.000	0.998	0.002
H93.2 Other abnormal auditory perceptions	0.000	0.998	0.002
H93.0 Degenerative and vascular disorders of ear	0.000	0.998	0.002
M89.87 Other specified disorders of bone (Ankle and foot)	0.002	0.998	0.000
A04.7 Enterocolitis due to Clostridium difficile	0.000	0.998	0.002
I34.1 Mitral (valve) prolapse	0.000	0.998	0.002
K74.0 Hepatic fibrosis	0.000	0.998	0.002
R85.8 Other abnormal findings	0.002	0.998	0.000
J80 Adult respiratory distress syndrome	0.002	0.998	0.000
Q56 Indeterminate sex and pseudohermaphroditism	0.002	0.998	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.000	0.998	0.002
M96.6 Fracture of bone following insertion of orthopaedic implant, joint prosthesis or bone plate	0.000	0.998	0.002
M96.5 Postradiation scoliosis	0.000	0.998	0.002
M96.4 Postsurgical lordosis	0.000	0.998	0.002
M96.3 Postlaminectomy kyphosis	0.000	0.998	0.002
M96.2 Postradiation kyphosis	0.000	0.998	0.002
D03.9 Melanoma in situ, unspecified	0.002	0.998	0.000
D03.8 Melanoma in situ of other sites	0.002	0.998	0.000
D03.1 Melanoma in situ of eyelid, including canthus	0.002	0.998	0.000
D03.0 Melanoma in situ of lip	0.002	0.998	0.000
E34.0 Carcinoid syndrome	0.001	0.998	0.001
H93.9 Disorder of ear, unspecified	0.000	0.998	0.002
Q54.1 Hypospadias, penile	0.001	0.998	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.001	0.998	0.000
S32.41 Fracture of acetabulum (open)	0.001	0.998	0.000
Q55.6 Other congenital malformations of penis	0.001	0.998	0.000
S32.3 Fracture of ilium	0.001	0.998	0.000
H57 Other disorders of eye and adnexa	0.002	0.998	0.000
Q52 Other congenital malformations of female genitalia	0.001	0.998	0.000
R85 Abnormal findings in specimens from digestive organs and abdominal cavity	0.002	0.998	0.000
S32.21 Fracture of coccyx (open)	0.001	0.998	0.000
S32.20 Fracture of coccyx (closed)	0.001	0.998	0.000
M96.9 Postprocedural musculoskeletal disorder, unspecified	0.000	0.998	0.002
O41.0 Oligohydramnios	0.002	0.998	0.000
S32.40 Fracture of acetabulum (closed)	0.002	0.998	0.000
G93.4 Encephalopathy, unspecified	0.000	0.998	0.002
G93.1 Anoxic brain damage, not elsewhere classified	0.000	0.998	0.002
S32.1 Fracture of sacrum	0.001	0.998	0.000
S92.21 Fracture of other tarsal bone(s) (open)	0.001	0.998	0.000
J02.9 Acute pharyngitis, unspecified	0.000	0.998	0.002
K70.4 Alcoholic hepatic failure	0.000	0.998	0.002
Q55.2 Other congenital malformations of testis and scrotum	0.001	0.998	0.000
S92.9 Fracture of foot, unspecified	0.001	0.998	0.000
K74 Fibrosis and cirrhosis of liver	0.000	0.998	0.002
N93 Other abnormal uterine and vaginal bleeding	0.002	0.998	0.000
I42.9 Cardiomyopathy, unspecified	0.000	0.998	0.002
Q55.9 Congenital malformation of male genital organ, unspecified	0.001	0.998	0.000
Q55.8 Other specified congenital malformations of male genital organs	0.001	0.998	0.000
Q55.5 Congenital absence and aplasia of penis	0.001	0.998	0.000
Q55.4 Other congenital malformations of vas deferens, epididymis, seminal vesicles and prostate	0.001	0.998	0.000
Q55.3 Atresia of vas deferens	0.001	0.998	0.000
Q55.1 Hypoplasia of testis and scrotum	0.001	0.998	0.000
Q55.0 Absence and aplasia of testis	0.001	0.998	0.000
Z90.2 Acquired absence of lung [part of]	0.000	0.998	0.002
M81.98 Osteoporosis, unspecified (Other)	0.000	0.998	0.002
E34.9 Endocrine disorder, unspecified	0.001	0.998	0.001
G93.8 Other specified disorders of brain	0.000	0.998	0.002
H02.6 Xanthelasma of eyelid	0.002	0.998	0.000
L05.9 Pilonidal cyst without abscess	0.000	0.998	0.002
M89.8 Other specified disorders of bone	0.002	0.998	0.000
S92.71 Multiple fractures of foot (open)	0.001	0.998	0.000
D03.7 Melanoma in situ of lower limb, including hip	0.001	0.998	0.000
S92.1 Fracture of talus	0.001	0.998	0.000
Q53 Undescended testicle	0.001	0.998	0.000
M89.84 Other specified disorders of bone (Hand)	0.001	0.998	0.000
K74.5 Biliary cirrhosis, unspecified	0.000	0.998	0.001
R45.1 Restlessness and agitation	0.002	0.998	0.000
S62.6 Fracture of other finger	0.000	0.998	0.002
S92.0 Fracture of calcaneus	0.001	0.998	0.000
N26 Unspecified contracted kidney	0.000	0.998	0.002
M89.86 Other specified disorders of bone (Lower leg)	0.001	0.998	0.000
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.001	0.998	0.000
Q56.4 Indeterminate sex, unspecified	0.001	0.998	0.000
Q56.3 Pseudohermaphroditism, unspecified	0.001	0.998	0.000
Q56.2 Female pseudohermaphroditism, not elsewhere classified	0.001	0.998	0.000
Q56.1 Male pseudohermaphroditism, not elsewhere classified	0.001	0.998	0.000
Q56.0 Hermaphroditism, not elsewhere classified	0.001	0.998	0.000
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.000	0.998	0.001
M96.65 Fracture of pelvis following insertion of orthopedic implant, joint prosthesis, or bone plate (Fx pelvis following insrt ortho implnt/prosth/bone plt)	0.000	0.998	0.001
M96.63 Fracture of radius or ulna following insertion of orthopedic implant, joint prosthesis, or bone plate	0.000	0.998	0.001
K70.1 Alcoholic hepatitis	0.000	0.998	0.001
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.001	0.998	0.000
S92.4 Fracture of great toe	0.001	0.998	0.000
I42.0 Dilated cardiomyopathy	0.000	0.999	0.001
K29.2 Alcoholic gastritis	0.001	0.999	0.000
K83.0 Cholangitis	0.001	0.999	0.000
Q52.9 Congenital malformation of female genitalia, unspecified	0.001	0.999	0.000
Q52.8 Other specified congenital malformations of female genitalia	0.001	0.999	0.000
Q52.7 Other congenital malformations of vulva	0.001	0.999	0.000
Q52.6 Congenital malformation of clitoris	0.001	0.999	0.000
Q52.4 Other congenital malformations of vagina	0.001	0.999	0.000
Q52.3 Imperforate hymen	0.001	0.999	0.000
Q52.2 Congenital rectovaginal fistula	0.001	0.999	0.000
Q52.1 Doubling of vagina	0.001	0.999	0.000
Q52.0 Congenital absence of vagina	0.001	0.999	0.000
R85.9 Unspecified abnormal finding	0.001	0.999	0.000
R85.6 Abnormal cytological findings	0.001	0.999	0.000
R85.4 Abnormal immunological findings	0.001	0.999	0.000
R85.3 Abnormal level of substances chiefly nonmedicinal as to source	0.001	0.999	0.000
R85.2 Abnormal level of other drugs, medicaments and biological substances	0.001	0.999	0.000
R85.1 Abnormal level of hormones	0.001	0.999	0.000
R85.0 Abnormal level of enzymes	0.001	0.999	0.000
Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history	0.000	0.999	0.001
M23.51 Chronic instability of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.000	0.999	0.001
S32.31 Fracture of ilium (open)	0.001	0.999	0.000
S82.10 Fracture of upper end of tibia (closed)	0.000	0.999	0.001
S02.00 Fracture of vault of skull (closed)	0.001	0.999	0.000
S32.11 Fracture of sacrum (open)	0.001	0.999	0.000
R73.9 Hyperglycaemia, unspecified	0.000	0.999	0.001
S92.91 Fracture of foot, unspecified (open)	0.001	0.999	0.000
S92.90 Fracture of foot, unspecified (closed)	0.001	0.999	0.000
K74.4 Secondary biliary cirrhosis	0.000	0.999	0.001
K74.2 Hepatic fibrosis with hepatic sclerosis	0.000	0.999	0.001
K74.1 Hepatic sclerosis	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations